Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice
Renal insufficiency is a frequent cancer-associated problem affecting more than half of all cancer patients at the time of diagnosis. To minimize nephrotoxic effects the dosage of anticancer drugs are reduced in these patients, leading to sub-optimal treatment efficacy. Despite the severity of this...
Main Authors: | Jessica Cedervall, Anca Dragomir, Falk Saupe, Yanyu Zhang, Johan Ärnlöv, Erik Larsson, Anna Dimberg, Anders Larsson, Anna-Karin Olsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-08-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2017.1320009 |
Similar Items
-
Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis
by: Yudong Liu, et al.
Published: (2018-07-01) -
Candida albicans-Induced NETosis Is Independent of Peptidylarginine Deiminase 4
by: Eva Guiducci, et al.
Published: (2018-07-01) -
Paracoccidioides brasiliensis Releases a DNase-Like Protein That Degrades NETs and Allows for Fungal Escape
by: Yohan Ricci Zonta, et al.
Published: (2021-02-01) -
Therapeutic Targeting of Neutrophil Extracellular Traps Improves Primary and Secondary Intention Wound Healing in Mice
by: Annika Heuer, et al.
Published: (2021-02-01) -
NETosis in cancer - platelet neutrophil crosstalk promote tumor-associated pathology
by: Anna-Karin Olsson, et al.
Published: (2016-09-01)